Case_id: case_190
Case_description: 
A 23-year-old college student presents to the clinic with a history of intermittent chest discomfort. He reports that, about once per month for the past 8 or 9 months, he's had episodes of "feeling like my chest is going to explode." During these episodes, he also feels shortness of breath, feels shakiness throughout his arms and legs, and sweats so heavily that he needs to change his shirt. He is unsure of any clear precipitating factors but thinks they may occur more often around important exams or when big school projects are due. He shares that, as these episodes continue to recur, he has had mounting anxiety about having one when he is in class or at a restaurant. As a result, he is leaving the house less and less. He has no past medical history; the physical exam is unremarkable. Which of the following is the best medication for the long-term management of this patient's condition?
Options: 
1. Citalopram
2. Lithium
3. Lorazepam
4. Propranolol
5. Quetiapine
Correct Answer: Citalopram

================================================================================
Launch the MCC process
================================================================================
GPT is reasoning the answer...

GPT's diagnostic conclusion:
Choice: Option 1 (Citalopram)

GPT's full response:
================================================================================
**1. Case Summary and Key Symptoms**  
- **Patient Information:** 23-year-old male college student with no past medical history.  
- **Chief Complaint:** Intermittent chest discomfort described as "feeling like my chest is going to explode."  
- **Key Clinical Manifestations:**  
  - Episodes occur approximately once per month over the past 8-9 months.  
  - Associated symptoms during episodes include shortness of breath, shakiness in arms and legs, and heavy sweating requiring a change of shirt.  
  - Possible correlation with stressors such as important exams or major school projects.  
  - Increasing anxiety about having episodes in public settings (e.g., class, restaurants), leading to social avoidance and reduced house leaving.  
- **Physical Exam:** Unremarkable.

**2. Analysis of Clinical Features**  
The patient's recurrent episodes characterized by sudden onset of intense fear or discomfort, accompanied by physical symptoms like chest discomfort, shortness of breath, shakiness, and sweating, are indicative of panic attacks. The absence of identifiable precipitating factors, coupled with the anticipation of future attacks leading to behavioral changes (social avoidance), aligns with a diagnosis of Panic Disorder. The timeline of approximately monthly episodes over several months supports a chronic condition rather than an acute or transient issue. The lack of physical findings on examination further points towards a psychiatric etiology rather than a primary cardiac or respiratory disorder.

**3. Differential Diagnosis Analysis**  
- **Option 1: Citalopram**  
  - **Alignment:** Citalopram, an SSRI, is first-line for Panic Disorder as it addresses both acute and chronic symptoms by modulating serotonin levels, reducing the frequency and severity of panic attacks, and alleviating associated anxiety.
  
- **Option 2: Lithium**  
  - **Alignment:** Primarily used for bipolar disorder; not indicated for Panic Disorder. 
  
- **Option 3: Lorazepam**  
  - **Alignment:** Benzodiazepines like lorazepam are effective for acute anxiety relief but are not recommended for long-term management due to risks of dependence and tolerance.
  
- **Option 4: Propranolol**  
  - **Alignment:** Useful for performance anxiety and physical symptom control but not the first-line treatment for Panic Disorder.
  
- **Option 5: Quetiapine**  
  - **Alignment:** An atypical antipsychotic not typically used for Panic Disorder; more suited for schizophrenia or bipolar disorder.

Based on clinical guidelines and the patient's presentation, Citalopram is the most appropriate choice for long-term management.

**4. Final Selection**  
**My final selection is: Option 1 (Citalopram) (Citalopram 西酞普兰)**
================================================================================
Qwen is reasoning the answer...

Qwen's diagnostic conclusion:
Choice: Option 1 (Citalopram)

Qwen's full response:
================================================================================
**1. Case Summary and Key Symptoms**  
- A 23-year-old college student presents with recurrent episodes of chest tightness ("feeling like the chest is going to explode"), shortness of breath, tremors, and profuse sweating. These episodes occur approximately monthly for 9 months, often around stressors like exams or projects.  
- **Decisive symptoms**: Episodic autonomic hyperactivity (tremors, sweating), chest discomfort, and avoidance behavior due to fear of recurrent episodes, suggesting anxiety-related pathology.  

**2. Analysis of Clinical Features**  
- **Timeline and Triggers**: Symptoms occur episodically, with possible stress-related triggers (academic pressures). The episodes are time-limited but recurrent, consistent with panic attacks.  
- **Symptom Characteristics**: The autonomic symptoms (tremors, sweating) and chest discomfort align with panic disorder. The patient’s avoidance of public settings due to anxiety about future episodes suggests comorbid agoraphobia.  
- **Exclusion of Organic Causes**: Normal physical exam and no past medical history rule out cardiac, respiratory, or metabolic causes (e.g., asthma, hyperthyroidism).  

**3. Differential Diagnosis Analysis**  
- **Option 1 (Citalopram)**: An SSRI effective for panic disorder and anxiety disorders. It addresses both core anxiety symptoms and prevents recurrence. Long-term use is safe and aligned with clinical guidelines.  
- **Option 2 (Lithium)**: Used for bipolar disorder, not indicated here. No evidence of mood instability or cycling.  
- **Option 3 (Lorazepam)**: A benzodiazepine useful for acute panic episodes but high risk of dependence with long-term use. Not first-line for maintenance.  
- **Option 4 (Propranolol)**: A beta-blocker that alleviates physical symptoms (tremors, palpitations) but does not address underlying anxiety or panic. Not optimal for long-term management.  
- **Option 5 (Quetiapine)**: An antipsychotic used for schizophrenia or bipolar disorder. No psychotic features noted; not appropriate for anxiety.  

**4. Final Selection**  
**My final selection is: Option 1 (Citalopram)(西塔普拉姆)**  

**Key Evidence Supporting Choice**:  
- Panic disorder with agoraphobia is the most likely diagnosis, given episodic autonomic symptoms, stress triggers, and avoidance behavior.  
- SSRIs like citalopram are first-line for long-term management of panic disorder, as they reduce symptom severity and prevent recurrence.  
- Other options are either contraindicated (lithium, quetiapine), carry dependency risks (lorazepam), or only address physical symptoms (propranolol).
================================================================================
DeepSeek is reasoning the answer...

DeepSeek's diagnostic conclusion:
Choice: Option 1 (Citalopram)

DeepSeek's full response:
================================================================================
**1. Case Summary and Key Symptoms**  
- **Patient**: 23-year-old male college student.  
- **Chief Complaint**: Intermittent chest discomfort, recurring monthly for 8–9 months.  
- **Key Symptoms**:  
  - Episodic chest pressure ("feeling like my chest is going to explode").  
  - Shortness of breath, tremors (shakiness in limbs), profuse sweating.  
  - Symptoms triggered by stressors (exams, school deadlines).  
  - Avoidance behavior (leaving home less due to fear of episodes in public).  
- **Decisive Features**: Recurrent panic-like attacks, anticipatory anxiety, stress-related triggers, and functional impairment (social avoidance).  

**2. Analysis of Clinical Features**  
- **Timeline**: Episodes are intermittent (monthly), chronic (8–9 months), and worsening due to avoidance behavior.  
- **Symptom Characteristics**:  
  - Autonomic hyperactivity (sweating, tremors) and chest discomfort mimic panic attacks.  
  - Psychological component (anxiety about future episodes) aligns with panic disorder.  
- **Triggers**: Stressors (academic pressure) are classic precipitating factors for panic disorder.  
- **Physical Exam**: Unremarkable, ruling out acute cardiopulmonary pathology.  
- **Support for Panic Disorder**:  
  - Recurrent, unexpected panic attacks + anticipatory anxiety + avoidance behavior.  
  - Absence of medical comorbidities or substance use.  

**3. Differential Diagnosis Analysis**  
1. **Citalopram (SSRI)**:  
   - **Alignment**: First-line for panic disorder per guidelines (APA, NICE). SSRIs reduce attack frequency, improve anticipatory anxiety, and prevent relapse.  
   - **Evidence**: Long-term efficacy and safety in anxiety disorders.  
2. **Lithium (Mood stabilizer)**:  
   - **Misalignment**: Used for bipolar disorder, not panic disorder. No evidence of mood cycling or mania here.  
3. **Lorazepam (Benzodiazepine)**:  
   - **Partial Alignment**: Rapid relief for acute anxiety but unsuitable for long-term use (risk of dependence, tolerance).  
4. **Propranolol (Beta-blocker)**:  
   - **Partial Alignment**: Reduces physical symptoms (tremors, palpitations) but ineffective for preventing panic attacks or addressing core anxiety.  
5. **Quetiapine (Antipsychotic)**:  
   - **Misalignment**: Reserved for refractory cases or comorbid psychosis. No psychotic features here; excessive side-effect burden.  

**4. Final Selection**  
**My final selection is: Option 1 (Citalopram)(西酞普兰)**  
- **Key Evidence**:  
  - Patient meets diagnostic criteria for panic disorder with anticipatory anxiety and avoidance.  
  - SSRIs (e.g., citalopram) are guideline-recommended first-line therapy for long-term management.  
  - Addresses both acute panic symptoms and underlying anxiety, reduces relapse risk, and avoids benzodiazepine dependency.
================================================================================

The three models have reached an initial consensus!
Correct Answer: Option 1 (Citalopram)

GPT's initial diagnosis is correct
Qwen's initial diagnosis is correct
DeepSeek's initial diagnosis is correct

The three models have reached an initial consensus!All models selected Option1

========= Final Debate Result =========
GPT, Qwen, and DeepSeek-R1 have reached a consensus!
Final diagnosis: Option1 - Citalopram
Correct Answer: - Citalopram

Is the final diagnosis correct? ✓ Correct

